Governance and Decision Cadence for Complex Pharma Programs

Governance is often mistaken for meeting structure. Effective governance is a decision system: it directs the right issue to the right owner with the right information early enough to protect the program.

Start With Decision Rights

Define which decisions belong to workstream leaders, the program team, a decision board, and executive steering. Clarify who recommends, who decides, who must be consulted, and who is informed.

Create Tiered Forums

Workstream cadence

Manage deliverables, near-term dependencies, and local issues.

Integrated program review

Evaluate cross-functional milestones, risks, schedule impact, resource conflicts, and decisions.

Decision forum

Resolve prepared decisions with documented options, tradeoffs, recommendation, and required date.

Executive steering

Address enterprise tradeoffs, material risk, funding, scope, and escalated accountability.

Use Decision Service Levels

Set expected decision timing based on criticality. Track decision age, required-by date, schedule exposure, and accountable decision owner. A technically sound governance model can still fail if decisions move slower than the program.

Improve the Quality of Inputs

Decision requests should state the decision, why it is needed, options, impacts, recommendation, deadline, and consequence of delay. Avoid sending executives raw issue histories and expecting them to find the decision.

Connect Governance to the Schedule

Link major decisions to milestones and critical-path activities. The integrated schedule should expose when delayed decisions will consume float or change the launch sequence.

Business Takeaway

Strong governance reduces ambiguity and decision latency. It does not add bureaucracy; it makes accountability and tradeoffs visible at the speed the program requires.

CTA: RCG can help design a governance model that connects decisions, risks, and schedule control. Discuss your governance needs: https://readinessconsultinggroup.com/get-started.

Previous
Previous

Quality and Operations Handoffs in GxP Environments

Next
Next

Pharma Site Readiness: From Project Handover to Stable Operations